Literature DB >> 21085108

Antigen specific killing assay using CFSE labeled target cells.

Marina Durward1, Jerome Harms, Gary Splitter.   

Abstract

Carboxyfluorescein diacetate succinimidyl ester (CFSE) can be used to easily and quickly label a cell population of interest for in vivo investigation. This labeling has classically been used to study proliferation and migration. In the method presented here, we have shortened the timeline after adoptive transfer to look at survival and killing of epitope specific CFSE labeled target cells. The level of specific killing of a CD8 + T cell clone can indicate the quality of the response, as their quantity may be misleading. Specific CD8+ T cells can become functionally exhausted over time with a decline in cytokine production and killing. Also, certain CD8 + T cell clones may not kill as well as others with differing TCR specificities. For effective Cell Mediated Immunity (CMI), antigens must be identified that produce not only adequate numbers of responding T cells, but also functionally robust responding T cells. Here we assess the percent cell specific killing of two peptide specific T cell clones in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085108      PMCID: PMC3159590          DOI: 10.3791/2250

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

1.  New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy.

Authors:  S A Weston; C R Parish
Journal:  J Immunol Methods       Date:  1990-10-04       Impact factor: 2.303

Review 2.  Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells.

Authors:  Elizabeth Ingulli
Journal:  Methods Mol Biol       Date:  2007

3.  Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution.

Authors:  Paul K Wallace; Joseph D Tario; Jan L Fisher; Stephen S Wallace; Marc S Ernstoff; Katharine A Muirhead
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

4.  Determination of lymphocyte division by flow cytometry.

Authors:  A B Lyons; C R Parish
Journal:  J Immunol Methods       Date:  1994-05-02       Impact factor: 2.303

5.  Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.

Authors:  Janine Suffner; Kristin Hochweller; Marie-Cristine Kühnle; Xingrui Li; Richard A Kroczek; Natalio Garbi; Günter J Hämmerling
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

6.  Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection.

Authors:  Joseph N Blattman; E John Wherry; Sang-Jun Ha; Robbert G van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

7.  Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Authors:  Marina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

8.  The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.

Authors:  Rama S Akondy; Nathan D Monson; Joseph D Miller; Srilatha Edupuganti; Dirk Teuwen; Hong Wu; Farah Quyyumi; Seema Garg; John D Altman; Carlos Del Rio; Harry L Keyserling; Alexander Ploss; Charles M Rice; Walter A Orenstein; Mark J Mulligan; Rafi Ahmed
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Differential preferences in serosal homing and distribution of peritoneal B-cell subsets revealed by in situ CFSE labeling.

Authors:  Arpád Lábadi; Péter Balogh
Journal:  Int Immunol       Date:  2009-07-22       Impact factor: 4.823

10.  The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse.

Authors:  Misty R Jenkins; Andy Tsun; Jane C Stinchcombe; Gillian M Griffiths
Journal:  Immunity       Date:  2009-10-16       Impact factor: 43.474

  10 in total
  23 in total

1.  IL-10 producing CD8+ CD122+ PD-1+ regulatory T cells are expanded by dendritic cells silenced for Allograft Inflammatory Factor-1.

Authors:  Diana M Elizondo; Temesgen E Andargie; Naomi L Haddock; Ricardo L Louzada da Silva; Tatiana Rodrigues de Moura; Michael W Lipscomb
Journal:  J Leukoc Biol       Date:  2018-12-04       Impact factor: 4.962

2.  Delivery of foreign cytotoxic T lymphocyte epitopes to tumor tissues for effective antitumor immunotherapy against pre-established solid tumors in mice.

Authors:  Herbert W Kavunja; Shuyao Lang; Suttipun Sungsuwan; Zhaojun Yin; Xuefei Huang
Journal:  Cancer Immunol Immunother       Date:  2016-12-23       Impact factor: 6.968

3.  Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.

Authors:  Irina Isakova-Sivak; Daniil Korenkov; Tatiana Smolonogina; Tatiana Tretiak; Svetlana Donina; Andrey Rekstin; Anatoly Naykhin; Svetlana Shcherbik; Nicholas Pearce; Li-Mei Chen; Tatiana Bousse; Larisa Rudenko
Journal:  Virology       Date:  2016-11-06       Impact factor: 3.616

4.  In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model.

Authors:  Cara L Haymaker; Yared Hailemichael; Yi Yang; Roza Nurieva
Journal:  J Vis Exp       Date:  2017-11-28       Impact factor: 1.355

5.  Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site.

Authors:  Tatiana Kotomina; Daniil Korenkov; Victoria Matyushenko; Polina Prokopenko; Larisa Rudenko; Irina Isakova-Sivak
Journal:  Hum Vaccin Immunother       Date:  2018-08-29       Impact factor: 3.452

6.  Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Authors:  Lionel Apetoh; Mark J Smyth; Charles G Drake; Jean-Pierre Abastado; Ron N Apte; Maha Ayyoub; Jean-Yves Blay; Marc Bonneville; Lisa H Butterfield; Anne Caignard; Chiara Castelli; Federica Cavallo; Esteban Celis; Lieping Chen; Mario P Colombo; Begoña Comin-Anduix; Georges Coukos; Madhav V Dhodapkar; Glenn Dranoff; Ian H Frazer; Wolf-Hervé Fridman; Dmitry I Gabrilovich; Eli Gilboa; Sacha Gnjatic; Dirk Jäger; Pawel Kalinski; Howard L Kaufman; Rolf Kiessling; John Kirkwood; Alexander Knuth; Roland Liblau; Michael T Lotze; Enrico Lugli; Francesco Marincola; Ignacio Melero; Cornelis J Melief; Thorsten R Mempel; Elizabeth A Mittendorf; Kunle Odun; Willem W Overwijk; Anna Karolina Palucka; Giorgio Parmiani; Antoni Ribas; Pedro Romero; Robert D Schreiber; Gerold Schuler; Pramod K Srivastava; Eric Tartour; Danila Valmori; Sjoerd H van der Burg; Pierre van der Bruggen; Benoît J van den Eynde; Ena Wang; Weiping Zou; Theresa L Whiteside; Daniel E Speiser; Drew M Pardoll; Nicholas P Restifo; Ana C Anderson
Journal:  Oncoimmunology       Date:  2015-02-25       Impact factor: 8.110

7.  Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.

Authors:  Jian Hang Lam; Yen Leong Chua; Pei Xuan Lee; Julia María Martínez Gómez; Eng Eong Ooi; Sylvie Alonso
Journal:  JCI Insight       Date:  2017-12-21

8.  The use of fluorescent target arrays for assessment of T cell responses in vivo.

Authors:  Benjamin J C Quah; Danushka K Wijesundara; Charani Ranasinghe; Christopher R Parish
Journal:  J Vis Exp       Date:  2014-06-19       Impact factor: 1.355

9.  Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.

Authors:  Jessie Thalmensi; Elodie Pliquet; Christelle Liard; Marie Escande; Thomas Bestetti; Marion Julithe; Anna Kostrzak; Anne-Sophie Pailhes-Jimenez; Emanuèle Bourges; Maria Loustau; Julien Caumartin; Abderrahim Lachgar; Thierry Huet; Simon Wain-Hobson; Pierre Langlade-Demoyen
Journal:  Oncoimmunology       Date:  2015-11-05       Impact factor: 8.110

10.  Cutting edge: Expression of FcγRIIB tempers memory CD8 T cell function in vivo.

Authors:  Gabriel R Starbeck-Miller; Vladimir P Badovinac; Daniel L Barber; John T Harty
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.